FDA Final Response

The Food and Drug Administration (FDA) has issued a final response concerning docket FDA-2022-P-2644-0046. This document, authored by the Center for Devices and Radiological Health (CDRH), is a final administrative action and does not appear to introduce new regulatory requirements or significant policy changes.

Compliance officers should note the publication date of March 27, 2026. While this is a final response, the lack of specific actionable items or deadlines suggests a routine update or informational posting. No immediate compliance actions are indicated, but awareness of the final response is recommended for entities involved with the docket.